What rigorous testing do medicines undergo before approval?

Question

Accepted Answer

Medicines Undergo Extensive Testing and Monitoring Before Approval

Medicines available in public hospitals undergo a rigorous, multi-stage testing and approval process designed to ensure their safety, efficacy, and quality before reaching patients. This comprehensive journey begins with extensive laboratory and animal studies to understand a drug's behaviour and potential toxicity. Subsequently, the compound progresses to human clinical trials, conducted in four distinct phases, each with specific objectives related to safety, dosage, effectiveness, and long-term effects. Post-approval, continuous monitoring through pharmacovigilance systems further safeguards public health by identifying any rare or unforeseen side effects.
Pre-clinical Laboratory and Animal Studies

Before any new drug can be tested in humans, it must first undergo laboratory and animal testing. These initial investigations explore how the substance interacts with biological systems, its pharmacokinetic properties (absorption, distribution, metabolism, and excretion), and its potential to cause harm. This stage is critical for identifying compounds that exhibit unacceptable toxicity, thereby preventing potentially dangerous substances from advancing to human trials. In addressing ethical considerations surrounding animal testing, researchers adhere to the internationally recognised "Three Rs" principles: replacing animal use with alternatives where possible, reducing the number of animals used, and refining experimental methods to minimise animal suffering.
Clinical Trials in Four Phases

Once a compound demonstrates acceptable safety in pre-clinical studies, it proceeds to human clinical trials, which are systematically divided into four phases. Phase 1 trials involve a small group of healthy volunteers to assess initial safety, identify common side effects, and determine a safe dosage range. Phase 2 trials are then conducted with patients who have the specific condition the drug is intended to treat, aiming to evaluate its effectiveness and further assess its safety profile. Phase 3 trials expand to involve a larger cohort of patients, often numbering in the hundreds or thousands, to compare the new treatment against existing standard therapies. The data generated from Phase 3 is paramount for securing regulatory approval.
Post-Marketing Surveillance

Following regulatory approval and the medicine's introduction into clinical practice, Phase 4 trials, also known as post-marketing surveillance, commence. This ongoing phase is crucial for monitoring the drug's performance in the general population over the long term. Its primary objective is to detect any rare or delayed adverse effects that may not have been apparent during the earlier, more controlled trial phases. This continuous oversight allows regulatory bodies and manufacturers to identify and address any emerging safety concerns, ensuring that the medicine's benefits continue to outweigh its risks throughout its lifecycle.

Reading history

Hide →

This history is cleared when the page is closed.

What rigorous testing do medicines undergo before approval?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends